Starpharma Holdings Limited (ASX: SPL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Starpharma Holdings Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Starpharma Holdings Limited (ASX: SPL)
Latest News
Share Gainers
Why the Starpharma share price rocketed 14% higher today
Share Market News
Starpharma share price surges 9.6% after ASX investor presentation release
Share Market News
Bell Potter upgrades Clinuvel Pharmaceuticals Limited to a buy
Share Gainers
Why the Clinuvel share price is up 150% over the past year
Share Fallers
The Starpharma Holdings share price slumped 10.5% on Wednesday
Share Fallers
Why Catapult, Inghams Group, Speedcast, and Starpharma shares dropped lower today
Share Gainers
Why Adairs, Metro Mining, Starpharma, and Syrah Resources shares are higher on Monday
Share Fallers
Insider share buying can't stop the Starpharma share price sliding again today
Share Fallers
Why Audio Pixels, BWP Trust, DEXUS Property, and Starpharma shares are in the red today
Share Fallers
Why the Starpharma share price is tanking on an FDA rejection
Share Gainers
Why AGL Energy, Creso Pharma, RPMGlobal, and Starpharma shares pushed higher today
Share Gainers
Why these 4 ASX shares have climbed higher today
Frequently Asked Questions
-
No, Starpharma does not pay dividends at this time.
-
Starpharma listed on the ASX on 28 September 2000.
SPL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Starpharma Holdings Limited
Starpharma Holdings Ltd (ASX: SPL) is an Australian biotechnology company involved in the development of dendrimer products for pharmaceutical, life science, and other applications.
Dendrimers are synthetically manufactured, nanoscale molecules, particularly useful to the pharmaceutical industry for their unique properties as carriers of other molecular structures.
Starpharma describes itself as a world leader in the field. The company is developing programs for drug delivery applications, the treatment of respiratory viruses, and its VivaGel product.
VivaGel can be used for the management and prevention of bacterial vaginosis and as a coating for condoms. The company's VIRALEZE product is an antiviral nasal spray approved for use in many countries, including Europe and the UK.
